nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—KCNJ1—appendage—skin cancer	0.113	0.393	CbGeAlD
Tolazamide—ABCC8—penis—skin cancer	0.0977	0.339	CbGeAlD
Tolazamide—Hyponatraemia—Vismodegib—skin cancer	0.0268	0.0377	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Docetaxel—skin cancer	0.0232	0.0325	CcSEcCtD
Tolazamide—Eruption—Dactinomycin—skin cancer	0.0209	0.0294	CcSEcCtD
Tolazamide—KCNJ1—head—skin cancer	0.0191	0.066	CbGeAlD
Tolazamide—Digestion impaired—Temozolomide—skin cancer	0.0174	0.0244	CcSEcCtD
Tolazamide—Heartburn—Fluorouracil—skin cancer	0.0156	0.0219	CcSEcCtD
Tolazamide—KCNJ11—lymphoid tissue—skin cancer	0.0143	0.0497	CbGeAlD
Tolazamide—KCNJ11—female reproductive system—skin cancer	0.0138	0.0479	CbGeAlD
Tolazamide—Photosensitivity reaction—Vemurafenib—skin cancer	0.013	0.0183	CcSEcCtD
Tolazamide—Eruption—Docetaxel—skin cancer	0.0126	0.0177	CcSEcCtD
Tolazamide—Aplastic anaemia—Dactinomycin—skin cancer	0.0121	0.017	CcSEcCtD
Tolazamide—Dyspepsia—Vismodegib—skin cancer	0.0116	0.0162	CcSEcCtD
Tolazamide—KCNJ11—head—skin cancer	0.0116	0.04	CbGeAlD
Tolazamide—Pancytopenia—Imiquimod—skin cancer	0.0116	0.0162	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Vismodegib—skin cancer	0.0113	0.0159	CcSEcCtD
Tolazamide—Fatigue—Vismodegib—skin cancer	0.0113	0.0159	CcSEcCtD
Tolazamide—Heartburn—Docetaxel—skin cancer	0.0112	0.0158	CcSEcCtD
Tolazamide—Photosensitivity reaction—Imiquimod—skin cancer	0.0111	0.0156	CcSEcCtD
Tolazamide—Aplastic anaemia—Temozolomide—skin cancer	0.0109	0.0153	CcSEcCtD
Tolazamide—ABCC8—head—skin cancer	0.0106	0.0369	CbGeAlD
Tolazamide—Erythema—Vemurafenib—skin cancer	0.00994	0.014	CcSEcCtD
Tolazamide—Asthenia—Vismodegib—skin cancer	0.00942	0.0132	CcSEcCtD
Tolazamide—Pruritus—Vismodegib—skin cancer	0.00929	0.0131	CcSEcCtD
Tolazamide—Erythema—Imiquimod—skin cancer	0.00848	0.0119	CcSEcCtD
Tolazamide—Rash—Vismodegib—skin cancer	0.00828	0.0116	CcSEcCtD
Tolazamide—Pancytopenia—Bleomycin—skin cancer	0.00821	0.0115	CcSEcCtD
Tolazamide—KCNJ11—lymph node—skin cancer	0.00809	0.028	CbGeAlD
Tolazamide—Ill-defined disorder—Imiquimod—skin cancer	0.00786	0.0111	CcSEcCtD
Tolazamide—Nausea—Vismodegib—skin cancer	0.0078	0.011	CcSEcCtD
Tolazamide—Pancytopenia—Dactinomycin—skin cancer	0.00765	0.0108	CcSEcCtD
Tolazamide—Malaise—Imiquimod—skin cancer	0.00764	0.0107	CcSEcCtD
Tolazamide—Abdominal distension—Temozolomide—skin cancer	0.00734	0.0103	CcSEcCtD
Tolazamide—Discomfort—Imiquimod—skin cancer	0.00713	0.01	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.007	0.00984	CcSEcCtD
Tolazamide—Fatigue—Vemurafenib—skin cancer	0.00699	0.00983	CcSEcCtD
Tolazamide—Pancytopenia—Temozolomide—skin cancer	0.00692	0.00973	CcSEcCtD
Tolazamide—Agranulocytosis—Dactinomycin—skin cancer	0.00671	0.00943	CcSEcCtD
Tolazamide—Photosensitivity reaction—Temozolomide—skin cancer	0.00665	0.00935	CcSEcCtD
Tolazamide—Pancytopenia—Fluorouracil—skin cancer	0.00638	0.00897	CcSEcCtD
Tolazamide—Photosensitivity reaction—Fluorouracil—skin cancer	0.00613	0.00862	CcSEcCtD
Tolazamide—Dyspepsia—Imiquimod—skin cancer	0.00609	0.00856	CcSEcCtD
Tolazamide—Erythema—Bleomycin—skin cancer	0.00602	0.00847	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Imiquimod—skin cancer	0.00597	0.0084	CcSEcCtD
Tolazamide—Fatigue—Imiquimod—skin cancer	0.00596	0.00838	CcSEcCtD
Tolazamide—Asthenia—Vemurafenib—skin cancer	0.00582	0.00818	CcSEcCtD
Tolazamide—Pruritus—Vemurafenib—skin cancer	0.00574	0.00807	CcSEcCtD
Tolazamide—Feeling abnormal—Imiquimod—skin cancer	0.0057	0.00801	CcSEcCtD
Tolazamide—Hyponatraemia—Docetaxel—skin cancer	0.00563	0.00792	CcSEcCtD
Tolazamide—Erythema—Dactinomycin—skin cancer	0.00562	0.00789	CcSEcCtD
Tolazamide—Agranulocytosis—Fluorouracil—skin cancer	0.00559	0.00786	CcSEcCtD
Tolazamide—Ill-defined disorder—Bleomycin—skin cancer	0.00559	0.00785	CcSEcCtD
Tolazamide—Urticaria—Imiquimod—skin cancer	0.0055	0.00773	CcSEcCtD
Tolazamide—Malaise—Bleomycin—skin cancer	0.00543	0.00763	CcSEcCtD
Tolazamide—Leukopenia—Bleomycin—skin cancer	0.00539	0.00758	CcSEcCtD
Tolazamide—Dizziness—Vemurafenib—skin cancer	0.00536	0.00754	CcSEcCtD
Tolazamide—Ill-defined disorder—Dactinomycin—skin cancer	0.00521	0.00733	CcSEcCtD
Tolazamide—Rash—Vemurafenib—skin cancer	0.00511	0.00719	CcSEcCtD
Tolazamide—Headache—Vemurafenib—skin cancer	0.00508	0.00714	CcSEcCtD
Tolazamide—Erythema—Temozolomide—skin cancer	0.00508	0.00714	CcSEcCtD
Tolazamide—Discomfort—Bleomycin—skin cancer	0.00507	0.00712	CcSEcCtD
Tolazamide—Malaise—Dactinomycin—skin cancer	0.00506	0.00712	CcSEcCtD
Tolazamide—Leukopenia—Dactinomycin—skin cancer	0.00503	0.00707	CcSEcCtD
Tolazamide—Asthenia—Imiquimod—skin cancer	0.00496	0.00698	CcSEcCtD
Tolazamide—Pruritus—Imiquimod—skin cancer	0.00489	0.00688	CcSEcCtD
Tolazamide—Nausea—Vemurafenib—skin cancer	0.00482	0.00677	CcSEcCtD
Tolazamide—Thrombocytopenia—Bleomycin—skin cancer	0.00481	0.00676	CcSEcCtD
Tolazamide—Discomfort—Dactinomycin—skin cancer	0.00472	0.00664	CcSEcCtD
Tolazamide—Ill-defined disorder—Temozolomide—skin cancer	0.00471	0.00663	CcSEcCtD
Tolazamide—Erythema—Fluorouracil—skin cancer	0.00468	0.00658	CcSEcCtD
Tolazamide—Pancytopenia—Docetaxel—skin cancer	0.0046	0.00647	CcSEcCtD
Tolazamide—Malaise—Temozolomide—skin cancer	0.00458	0.00644	CcSEcCtD
Tolazamide—Dizziness—Imiquimod—skin cancer	0.00457	0.00643	CcSEcCtD
Tolazamide—Vertigo—Temozolomide—skin cancer	0.00456	0.00642	CcSEcCtD
Tolazamide—Leukopenia—Temozolomide—skin cancer	0.00455	0.00639	CcSEcCtD
Tolazamide—Thrombocytopenia—Dactinomycin—skin cancer	0.00449	0.00631	CcSEcCtD
Tolazamide—Rash—Imiquimod—skin cancer	0.00436	0.00613	CcSEcCtD
Tolazamide—Headache—Imiquimod—skin cancer	0.00433	0.00609	CcSEcCtD
Tolazamide—Discomfort—Temozolomide—skin cancer	0.00427	0.00601	CcSEcCtD
Tolazamide—Leukopenia—Fluorouracil—skin cancer	0.00419	0.00589	CcSEcCtD
Tolazamide—Nausea—Imiquimod—skin cancer	0.00411	0.00578	CcSEcCtD
Tolazamide—Thrombocytopenia—Temozolomide—skin cancer	0.00406	0.00571	CcSEcCtD
Tolazamide—Feeling abnormal—Bleomycin—skin cancer	0.00405	0.00569	CcSEcCtD
Tolazamide—Agranulocytosis—Docetaxel—skin cancer	0.00403	0.00567	CcSEcCtD
Tolazamide—Fatigue—Dactinomycin—skin cancer	0.00395	0.00556	CcSEcCtD
Tolazamide—Discomfort—Fluorouracil—skin cancer	0.00394	0.00553	CcSEcCtD
Tolazamide—Urticaria—Bleomycin—skin cancer	0.0039	0.00549	CcSEcCtD
Tolazamide—Feeling abnormal—Dactinomycin—skin cancer	0.00378	0.00531	CcSEcCtD
Tolazamide—Thrombocytopenia—Fluorouracil—skin cancer	0.00374	0.00526	CcSEcCtD
Tolazamide—Dyspepsia—Temozolomide—skin cancer	0.00365	0.00513	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Temozolomide—skin cancer	0.00358	0.00503	CcSEcCtD
Tolazamide—Fatigue—Temozolomide—skin cancer	0.00357	0.00502	CcSEcCtD
Tolazamide—Asthenia—Bleomycin—skin cancer	0.00353	0.00496	CcSEcCtD
Tolazamide—Pruritus—Bleomycin—skin cancer	0.00348	0.00489	CcSEcCtD
Tolazamide—Feeling abnormal—Temozolomide—skin cancer	0.00342	0.0048	CcSEcCtD
Tolazamide—Erythema—Docetaxel—skin cancer	0.00338	0.00475	CcSEcCtD
Tolazamide—Dyspepsia—Fluorouracil—skin cancer	0.00336	0.00473	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.0033	0.00464	CcSEcCtD
Tolazamide—Urticaria—Temozolomide—skin cancer	0.00329	0.00463	CcSEcCtD
Tolazamide—Asthenia—Dactinomycin—skin cancer	0.00329	0.00462	CcSEcCtD
Tolazamide—Feeling abnormal—Fluorouracil—skin cancer	0.00315	0.00442	CcSEcCtD
Tolazamide—Rash—Bleomycin—skin cancer	0.0031	0.00436	CcSEcCtD
Tolazamide—Urticaria—Fluorouracil—skin cancer	0.00303	0.00427	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—skin cancer	0.00302	0.00425	CcSEcCtD
Tolazamide—Asthenia—Temozolomide—skin cancer	0.00297	0.00418	CcSEcCtD
Tolazamide—Pruritus—Temozolomide—skin cancer	0.00293	0.00412	CcSEcCtD
Tolazamide—Nausea—Bleomycin—skin cancer	0.00292	0.0041	CcSEcCtD
Tolazamide—Rash—Dactinomycin—skin cancer	0.00289	0.00406	CcSEcCtD
Tolazamide—Dizziness—Temozolomide—skin cancer	0.00274	0.00385	CcSEcCtD
Tolazamide—Nausea—Dactinomycin—skin cancer	0.00272	0.00383	CcSEcCtD
Tolazamide—Pruritus—Fluorouracil—skin cancer	0.0027	0.0038	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—skin cancer	0.0027	0.00379	CcSEcCtD
Tolazamide—Rash—Temozolomide—skin cancer	0.00261	0.00367	CcSEcCtD
Tolazamide—Headache—Temozolomide—skin cancer	0.0026	0.00365	CcSEcCtD
Tolazamide—Dizziness—Fluorouracil—skin cancer	0.00253	0.00355	CcSEcCtD
Tolazamide—Nausea—Temozolomide—skin cancer	0.00246	0.00346	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—skin cancer	0.00243	0.00341	CcSEcCtD
Tolazamide—Rash—Fluorouracil—skin cancer	0.00241	0.00339	CcSEcCtD
Tolazamide—Headache—Fluorouracil—skin cancer	0.00239	0.00336	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Docetaxel—skin cancer	0.00238	0.00335	CcSEcCtD
Tolazamide—Fatigue—Docetaxel—skin cancer	0.00238	0.00334	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—skin cancer	0.00227	0.00319	CcSEcCtD
Tolazamide—Nausea—Fluorouracil—skin cancer	0.00227	0.00319	CcSEcCtD
Tolazamide—Asthenia—Docetaxel—skin cancer	0.00198	0.00278	CcSEcCtD
Tolazamide—Pruritus—Docetaxel—skin cancer	0.00195	0.00274	CcSEcCtD
Tolazamide—Dizziness—Docetaxel—skin cancer	0.00182	0.00256	CcSEcCtD
Tolazamide—Rash—Docetaxel—skin cancer	0.00174	0.00244	CcSEcCtD
Tolazamide—Headache—Docetaxel—skin cancer	0.00173	0.00243	CcSEcCtD
Tolazamide—Nausea—Docetaxel—skin cancer	0.00164	0.0023	CcSEcCtD
